Current Editions
Biosecure Act revisions to target Medicare, Medicaid, VA reimbursement
Release of new version expected soon from Select Committee on the Chinese Communist Party
Politics, Policy & Law
BIO survey shows impacts of Biosecure Act
Abrupt decoupling from Chinese CDMOs and CMOs would devastate patients, biopharmas
Politics, Policy & Law
Emerging Company Profile
Avicenna: Using machine learning to skip the hit-to-lead phase
Seeded by DCVC Bio, Avicenna’s machine learning tech is designed to find a clinical candidate in a haystack of theoretical compounds
Finance
Bio€quity Europe 2024 preview: Rising above the noise
Looking ahead to the twenty-fourth incarnation of BioCentury’s European meeting
Management Tracks
Meyrick succeeding CMO Harris at radiopharma ITM
Plus: ALX hires Dillon and updates from Obsidian, YS and more
BioCentury ISSN 1097-7201